Filing Details
- Accession Number:
- 0001127602-16-055225
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2016-06-09 17:09:41
- Reporting Period:
- 2016-06-08
- Filing Date:
- 2016-06-09
- Accepted Time:
- 2016-06-09 17:09:41
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1082554 | United Therapeutics Corp | UTHR | Pharmaceutical Preparations (2834) | 521984749 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1324863 | G Tommy Thompson | 1040 Spring St. Silver Spring MD 20910 | Yes | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2016-06-08 | 2,000 | $52.65 | 2,000 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2016-06-08 | 2,000 | $115.62 | 0 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Stock Options | Disposition | 2016-06-08 | 2,000 | $0.00 | 2,000 | $52.65 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 18,000 | 2011-01-01 | 2020-01-01 | No | 4 | M | Direct |
Footnotes
- This transaction was executed in multiple trades at prices ranging from $115.37 to $115.82. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
Billionaire Hedge Funds
